Trevor Hallam's most recent trade in Sutro Biopharma Inc was a trade of 3,750 Common Stock done . Disclosure was reported to the exchange on April 14, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sutro Biopharma Inc | Trevor Hallam | Pres. Rsrch & Cf. Sctific Ofcr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Apr 2023 | 3,750 | 101,664 (0%) | 0% | 0 | Common Stock | |
| Sutro Biopharma Inc | Trevor Hallam | Pres. Rsrch & Cf. Sctific Ofcr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Apr 2023 | 3,750 | 7,500 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Trevor Hallam | Pres. Rsrch & Cf. Sctific Ofcr | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.40 per share. | 14 Apr 2023 | 1,296 | 100,368 (0%) | 0% | 4.4 | 5,702 | Common Stock |
| Sutro Biopharma Inc | Trevor Hallam | Pres. Rsrch & Cf. Sctific Ofcr | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 50,000 | 50,000 | - | - | Stock Option (right to buy Common Stock) | |
| Sutro Biopharma Inc | Trevor Hallam | Pres. Rsrch & Cf. Sctific Ofcr | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 40,000 | 40,000 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Trevor Hallam | Pres. Rsrch & Cf. Sctific Ofcr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2023 | 12,500 | 25,000 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Trevor Hallam | Pres. Rsrch & Cf. Sctific Ofcr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2023 | 12,500 | 105,631 (0%) | 0% | - | Common Stock | |
| Sutro Biopharma Inc | Trevor Hallam | Pres. Rsrch & Cf. Sctific Ofcr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2023 | 9,750 | 29,250 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Trevor Hallam | Pres. Rsrch & Cf. Sctific Ofcr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2023 | 9,750 | 93,131 (0%) | 0% | - | Common Stock | |
| Sutro Biopharma Inc | Trevor Hallam | Pres. Rsrch & Cf. Sctific Ofcr | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.79 per share. | 03 Mar 2023 | 7,717 | 97,914 (0%) | 0% | 5.8 | 44,681 | Common Stock |
| Sutro Biopharma Inc | Trevor Hallam | Pres. Rsrch & Cf. Sctific Ofcr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2023 | 5,250 | 5,250 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Trevor Hallam | Pres. Rsrch & Cf. Sctific Ofcr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2023 | 5,250 | 85,521 (0%) | 0% | 0 | Common Stock | |
| Sutro Biopharma Inc | Trevor Hallam | Pres. Rsrch & Cf. Sctific Ofcr | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.50 per share. | 27 Jan 2023 | 2,140 | 83,381 (0%) | 0% | 7.5 | 16,050 | Common Stock |
| Sutro Biopharma Inc | Trevor Hallam | Pres. Rsrch & Cf. Sctific Ofcr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Apr 2022 | 3,750 | 11,250 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Trevor Hallam | Pres. Rsrch & Cf. Sctific Ofcr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Apr 2022 | 3,750 | 81,567 (0%) | 0% | 0 | Common Stock | |
| Sutro Biopharma Inc | Trevor Hallam | Pres. Rsrch & Cf. Sctific Ofcr | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.26 per share. | 14 Apr 2022 | 1,296 | 80,271 (0%) | 0% | 7.3 | 9,409 | Common Stock |
| Sutro Biopharma Inc | Trevor Hallam | Pres. Rsrch & Cf. Sctific Ofcr | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2022 | 52,000 | 52,000 | - | - | Stock Option (right to buy Common Stock) | |
| Sutro Biopharma Inc | Trevor Hallam | Pres. Rsrch & Cf. Sctific Ofcr | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2022 | 39,000 | 39,000 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Trevor Hallam | Pres. Rsrch & Cf. Sctific Ofcr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2022 | 12,500 | 37,500 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Trevor Hallam | Pres. Rsrch & Cf. Sctific Ofcr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2022 | 12,500 | 82,095 (0%) | 0% | - | Common Stock | |
| Sutro Biopharma Inc | Trevor Hallam | Pres. Rsrch & Cf. Sctific Ofcr | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.17 per share. | 04 Mar 2022 | 4,278 | 77,817 (0%) | 0% | 8.2 | 34,951 | Common Stock |
| Sutro Biopharma Inc | Trevor Hallam | Pres. Rsrch & Cf. Sctific Ofcr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2022 | 5,250 | 10,500 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Trevor Hallam | Pres. Rsrch & Cf. Sctific Ofcr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2022 | 5,250 | 71,746 (0%) | 0% | 0 | Common Stock | |
| Sutro Biopharma Inc | Trevor Hallam | Pres. Rsrch & Cf. Sctific Ofcr | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.39 per share. | 29 Jan 2022 | 2,151 | 69,595 (0%) | 0% | 10.4 | 22,349 | Common Stock |
| Sutro Biopharma Inc | Trevor Hallam | Pres. Rsrch & Cf. Sctific Ofcr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Sep 2021 | 11,019 | 70,306 (0%) | 0% | 0 | Common Stock | |
| Sutro Biopharma Inc | Trevor Hallam | Pres. Rsrch & Cf. Sctific Ofcr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Sep 2021 | 11,019 | 0 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Trevor Hallam | Pres. Rsrch & Cf. Sctific Ofcr | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.23 per share. | 24 Sep 2021 | 3,810 | 66,496 (0%) | 0% | 19.2 | 73,266 | Common Stock |